Evaluation of Pharmacokinetics , Safety, Tolerability and Pharmacodynamics of Biocon Insulin Tregopil
Clinical trial NCT04141423 · TERMINATED
Trial details
- NCT number
- NCT04141423
- Sponsor
- Biocon Limited
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-28
- Primary completion
- 2021-04-23
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.